Search
News
Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.
News
Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future Therapies
Video
Strategies for Head and Neck Cancer: What to Look, Feel and Listen For
UCSF specialist Chase Heaton, MD, presents a guide to identifying head and neck cancers, including steps, tools and tips for a comprehensive exam; alarm-bell statements from your patients; and the one assumption you want to make about any neck lump.
News
Advancing Precision Medicine for Neuro-Oncology Patients: Q&A with David Solomon, MD, PhD
UC San Francisco neuropathologist and molecular neuro-oncologist David Solomon, MD, PhD has reached a unique and impressive milestone: the publication of his team's 50th neuro-oncology research study stemming from the UCSF500 Cancer Gene Panel, a molecular diagnostic test that identifies genetic changes in the DNA of a patient's cancer.
Video
Update on Liver Lesions: What Works in Managing HCC
Based on clear metrics, transplant hepatologist Neil Mehta, MD, presents diagnostic criteria for hepatocellular carcinoma, then shows how UCSF’s HCC team reaches decisions on treatment for individual cases – with plans ranging from resection or ablation to downstaging drugs and transplantation.
Document
Melanoma and Skin Cancer Program
Highly specialized care for patients with melanoma, Merkel Cell and other skin cancers
Video
Making Sense of MGUS: How to Detect Plasma Cell Disorders and Assess Associated Risks
Affecting up to 5% of the U.S. population (and increasingly common with age), monoclonal gammopathy of undetermined significance (MGUS) raises the risk of multiple myeloma, but – as its full name suggests – it can be hard to say by how much.
News
Post-Pandemic Cancer Care Delivery: Recovery or Redesign?
The COVID-19 pandemic has prompted major changes in the way clinicians deliver care, and nowhere have these changes been more urgent than in the field of oncology.
News
Renal Cell Carcinoma Research Sheds New Light on Advanced Disease
In a recent study, UCSF researchers found that renal cell carcinoma (RCC)with venous tumor thrombus(VTT) does not always signify metastatic disease with poor prognosis. These findings provide insight into the development of advanced RCC and may help to better inform surveillance regimens and treatment decisions and, ultimately, improve clinical outcomes.
Video
Navigating the Maze of Breast Cancer Guidelines: Efficient Paths to Personalized Screening
To help PCPs address patients’ breast cancer screening concerns, surgeon Shoko Emily Abe, MD, FACS, breaks down the multitude of screening directives and modalities, with a focus on the needs of those at average risk and those with dense breast tissue.
News
How Hungry Fat Cells Could Someday Starve Cancer to Death
Scientists transformed energy-storing white fat cells into calorie-burning ‘beige’ fat.
News
UCSF Awarded $12M Research Grant to Improve Cancer Outcomes
SPORE Grant from National Cancer Institute provides resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes.
News
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the world came together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research, technology and education.
Video
Mammography 101
Bonnie Joe, MD explains the differences between screening and diagnostic mammography, shows evidence for screening, answers common questions about radiation risk and false positives and discusses digital breast tomosynthesis, also known as 3D mammography.
News
Drug Turns Cancer Gene Into "Eat Me" Flag for Immune System
UCSF-led study shows promising pre-clinical results in killing cancer cells resistant to current KRAS-targeted treatments.
Video
The Human Microbiome and Breast Cancer
Immunologist Michael Campbell and breast cancer surgeon Laura Esserman speak at the April 2017 Bay Area Breast Cancer Forum about the human biome, how it’s being studied and how it relates to breast cancer prevention and treatment.
News
UCSF-Led Study Confirms Some Cancer Immunotherapies May Lead to Myocarditis and Other Potentially Serious Arrhythmias
Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis.
News
Powerful New Mini Microscopic Will Enable Precision Cancer Surgery
UCSF’s Mekhail Anwar wins an up to $15 million award from ARPA-H to develop a next-generation miniature scanner powerful enough to detect individual cancer cells during surgery.
